상세 보기
Proteomics
ISSN
P 1615-9853 E 1615-9861
출판사
John Wiley & Sons Ltd.
국가
USA
발행 상태
활성
데이터베이스 수록 정보
EMBASE 2016-2020 (5년)
JCR 2001-2019 (19년)
MEDLINE 2016-2021 (6년)
SCI 2010-2019 (10년)
SCIE 2010-2021 (12년)
Scopus 2017-2020 (4년)
SJR 2002-2019 (18년)
전체 53건 중 1번부터 10번까지의 결과를 표시합니다.
2025
Article
A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis
- Vachhani, Pankit ;
- Tan, Peter ;
- Watson, Anne-Marie ;
- Wu, Shang-Ju ;
- Baker, Ross ;
- ... Lee, Jae Hoon ;
- 외 17명
- 2025-10
- Haematologica
- FERRATA STORTI FOUNDATION
2024
Article
Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study
- Lee, Ji Hyun ;
- Choi, Jimin ;
- Min, Chang-Ki ;
- Park, Sung-Soo ;
- Jo, Jae-Cheol ;
- ... Lee, Jae Hoon ;
- 외 25명
- 2024-11
- Haematologica
- FERRATA STORTI FOUNDATION
Article
Long-term efficacy and safety of tucidinostat inpatients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results
- Rai, Shinya ;
- Kim, Won Seog ;
- Ando, Kiyoshi ;
- Choi, Ilseung ;
- Izutsu, Koji ;
- ... Lee, Jae Hoon ;
- 외 26명
- 2024-10
- Haematologica
- FERRATA STORTI FOUNDATION
2023
Article
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results
- Rai, Shinya ;
- Kim, Won Seog ;
- Ando, Kiyoshi ;
- Choi, Ilseung ;
- Izutsu, Koji ;
- ... Lee, Jae Hoon ;
- 외 26명
- 2023-03
- Haematologica
- FERRATA STORTI FOUNDATION
2020
Article
ACALABRUTINIB VS IDELALISIB PLUS RITUXIMAB (IDR) OR BENDAMUSTINE PLUS RITUXIMAB (BR) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF ASCEND
- Ghia, Paolo ;
- Pluta, Andrzej ;
- Wach, Malgorzata ;
- Lysak, Daniel ;
- Kozak, Tomas ;
- ... Lee, Jae Hoon ;
- 외 13명
- 2020-10
- Haematologica
- FERRATA STORTI FOUNDATION
2017
Article
UPDATED RESULTS OF CARFILZOMIB ASPIRE AND ENDEAVOR STUDIES, RANDOMIZED, OPEN, MULTICENTRIC, PHASE 3 IN PATIENTS (PTS) WITH MULTIPLE MYELOMA IN RECURRENCE/RESISTANT (MMRR)
- Oriol, A. ;
- Siegel, D. S. ;
- Rajnics, P. ;
- Minarik, J. ;
- Hungria, V ;
- ... Lee, J. H. ;
- 외 4명
- 2017-10
- Haematologica
- FERRATA STORTI FOUNDATION
Article
EFFICACY OF ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS WITH OR WITHOUT APLASTIC ANEMIA; PROSPECTIVE STUDY OF KOREAN PNH COHORT
- Choi, C. W. ;
- Jang, J. H. ;
- Kim, J. S. ;
- Jo, D-Y ;
- Lee, J-H ;
- ... Lee, J. H. ;
- 외 10명
- 2017-06
- Haematologica
- FERRATA STORTI FOUNDATION
Article
UPDATED RESULTS FROM ASPIRE AND ENDEAVOR, RANDOMISED, OPEN-LABEL, MULTICENTRE PHASE 3 STUDIES OF CARFILZOMIB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
- Siegel, D. ;
- Oriol, A. ;
- Rajnics, P. ;
- Minarik, J. ;
- Hungria, V. ;
- ... Lee, J. H. ;
- 외 4명
- 2017-06
- Haematologica
- FERRATA STORTI FOUNDATION
Article
BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
- Kim, M. K. ;
- Kim, K. ;
- Yoon, D. H. ;
- Suh, C. ;
- Moon, J. H. ;
- ... Lee, J. H. ;
- 외 12명
- 2017-06
- Haematologica
- FERRATA STORTI FOUNDATION
Article
CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB
- Do, Y. R. ;
- Kwak, J. -Y. ;
- Kim, H. ;
- Kim, J. -A. ;
- Kim, H. J. ;
- ... Park, J. ;
- 외 18명
- 2017-06
- Haematologica
- FERRATA STORTI FOUNDATION
1